Merck launches new $1B U.S. vaccine plant (MRK:NYSE)


Merck & Co. headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

  • Merck (NYSE:MRK) on Tuesday announced the opening of a new 225,000-square-foot facility constructed through a $1B investment to boost the company’s vaccine production in the U.S.
  • The maker of Gardasil and Gardasil 9 vaccines argued that the new plant, located in



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top